CN116376919A - 干扰许氏平由性腺正常发育的基因片段、重组菌及其应用 - Google Patents
干扰许氏平由性腺正常发育的基因片段、重组菌及其应用 Download PDFInfo
- Publication number
- CN116376919A CN116376919A CN202310586471.4A CN202310586471A CN116376919A CN 116376919 A CN116376919 A CN 116376919A CN 202310586471 A CN202310586471 A CN 202310586471A CN 116376919 A CN116376919 A CN 116376919A
- Authority
- CN
- China
- Prior art keywords
- schwann
- interfering
- gene fragment
- gonad
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 31
- 239000012634 fragment Substances 0.000 title claims abstract description 25
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 24
- 238000011161 development Methods 0.000 title claims abstract description 18
- 230000002452 interceptive effect Effects 0.000 title claims abstract description 17
- 210000002149 gonad Anatomy 0.000 title claims abstract description 16
- 241000251468 Actinopterygii Species 0.000 claims abstract description 15
- 210000004602 germ cell Anatomy 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000002773 nucleotide Substances 0.000 claims abstract description 5
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 5
- 230000001418 larval effect Effects 0.000 claims abstract description 4
- 230000018109 developmental process Effects 0.000 claims description 15
- 239000013598 vector Substances 0.000 claims description 10
- 241000700141 Rotifera Species 0.000 claims description 9
- 108091030071 RNAI Proteins 0.000 claims description 6
- 241000244206 Nematoda Species 0.000 claims description 5
- 230000009368 gene silencing by RNA Effects 0.000 claims description 5
- 239000001963 growth medium Substances 0.000 claims description 5
- 241001247197 Cephalocarida Species 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 4
- 239000008188 pellet Substances 0.000 claims description 4
- 241001131798 Escherichia coli HT115 Species 0.000 claims description 3
- 210000004907 gland Anatomy 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000024245 cell differentiation Effects 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000001902 propagating effect Effects 0.000 claims description 2
- 238000003197 gene knockdown Methods 0.000 abstract description 19
- 230000002710 gonadal effect Effects 0.000 abstract description 11
- 206010058314 Dysplasia Diseases 0.000 abstract description 4
- 230000004069 differentiation Effects 0.000 abstract description 4
- 230000001939 inductive effect Effects 0.000 abstract description 4
- 101150044508 key gene Proteins 0.000 abstract 1
- 210000001672 ovary Anatomy 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 7
- 210000001550 testis Anatomy 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 241000195974 Selaginella Species 0.000 description 3
- 108020004459 Small interfering RNA Proteins 0.000 description 3
- 241001052560 Thallis Species 0.000 description 3
- 238000003209 gene knockout Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 208000026487 Triploidy Diseases 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000018853 germ cell migration Effects 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 238000009403 interspecific hybridization Methods 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000007480 sanger sequencing Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 1
- 241001303562 Centrolophus niger Species 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 101150049432 dnd gene Proteins 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明涉及一种干扰许氏平由性腺正常发育的基因片段、重组菌及其应用,属于分子生物学领域,所述干扰片段的核苷酸序列如SEQ ID NO.1所示。本发明还提供包含所述基因片段的重组菌,将所述重组菌投喂处于原始生殖细胞分化期许氏平由仔鱼能够敲降原始生殖细胞发育关键基因dnd的表达,诱导产生性腺发育不良的个体,为许氏平由不育受体的获取提供了一种方法。
Description
技术领域
本发明属于分子生物学领域,具体涉及一种干扰许氏平由性腺正常发育的基因片段、重组菌及其应用。
背景技术
许氏平由(Sebastes schlegelii)隶属于鲉形目,鲉科,平鲉属,又称黑鲪,俗称黑鱼、黑寨、黑老婆等,是分布于太平洋西北部的一种近海底层鱼类。因其具有肉质细嫩,味道鲜美,能在北方自然越冬等优点,已成为我国北方重要的海水养殖经济鱼种。许氏平由生长性状呈现明显的性别二态性,同龄雌性个体比雄性个体大约25%。因此,开展许氏平由全雌群体养殖,可以提高养殖产量,具有良好的产业前景,将显著提升许氏平由的水产养殖效益。许氏平由为XY性别决定,通过过表达amhy产生XX伪雄鱼是诱导全雌群体的重要手段。然而,伪雄鱼存在性腺发育不良,精子存活率低等问题,制约着全雌群体的创建。生殖干细胞移植技术通过选择雌性个体,将其卵原细胞分离,并移植到雄性不育受体中,雄性受体可于交尾时产生全部为X型精子,待其与野生雌鱼交配后,可产生全雌群体。然而,生殖干细胞移植技术存在其技术瓶颈:由于可育受体含有自身的生殖细胞,当供体的生殖细胞成功嵌合到受体性腺时,受体的内源生殖细胞会同供体生殖细胞相互竞争发育所需的微环境,从而导致受体产生供体配子的比例很低。而不育受体可以实现仅产生供体来源的配子这一要求。因此,构建不育受体对于生殖干细胞移植技术的成功至关重要。
目前获取不育受体的途径包括人工诱导三倍体、种间杂交或使用激素处理导致性腺发育受阻等三种。然而前两种方法的高时间成本和经济成本,以及激素处理对环境的威胁,很大程度上限制了其在养殖过程中的应用。
发明内容
本发明的目的在于提供一种干扰许氏平由性腺正常发育的基因片段、重组菌及其应用,所述重组菌能够在原始生殖细胞分化期敲降许氏平由关键基因dnd的表达,能够诱导产生性腺发育受阻的个体,为许氏平由不育受体的获取提供了一种新型手段,同时也为许氏平由的原始生殖细胞移植提供了新的方法。
本发明通过以下方案来实现上述目的:一种干扰许氏平由性腺正常发育的基因片段,所述基因片段的核苷酸序列如SEQ ID NO.1所示。
一种干扰许氏平由性腺正常发育的重组菌,所述重组菌包括如SEQ ID NO.1所示基因片段、L4440线虫RNAi干扰载体和HT115菌株。
所述基因片段的核苷酸序列为:
gatgatggagaacaagcagagccaggtgctgaatgttgagcgggtgaaggcactggaaacctggctgaaagccaccaatacaaatctgaaacaagtaaacggccagaggaagtatggaggaccacctgaggtgtgggacgggccgtccccaggagcccgctgtgaggtcttcatcagccagatccctcgggacacctacgaggatctgctgattcccctcttcagctccgtggggcccctgtgggagttccggctcatgatgaatttcagcggccagaaccgcggcttcgcctacggcaaatacggctcgccggccgtagctactgaagccatccgcctgctgcacggtcacatgctggagcccggcttctgcctcagtgtccgccgcagcacggagaagagacacctctgtatcggaaacct。
本发明还提供所述重组菌的制备方法,将所述基因片段的核苷酸序列SEQ IDNO.1构建到L4440线虫RNAi干扰载体上,然后导入大肠杆菌HT115菌株,获得所述重组菌。
本发明还提供所述重组菌在干扰许氏平由性腺发育中的应用,所述应用方法如下:将所述重组菌培养扩繁至OD值 0.4,诱导后,按照1mL重悬培养基/200mL初始菌量的比例重悬菌体,按照1mL/200条鱼/天的比例吸取重悬后的诱导菌,混入饵料,对处于原始生殖细胞分化期许氏平由仔鱼进行投喂,投喂周期为90天。
进一步,投喂时间为从许氏平由幼体生后5天开始,至出生后95天结束。
进一步,所述的饵料依次为轮虫、卤虫和颗粒饲料。
本发明与现有技术相比的有益效果:(1)本发明建立了一种全新的获取不育受体的技术,相比于传统的人工诱导产生三倍体、种间杂交等技术,具有省时省力、经济高效的特点。(2)本发明所述干扰片段能够抑制原始生殖细胞标记基因的表达,获得性腺发育不良的许氏平由苗种,本发明方法相对于激素诱导的性腺不育方式,特异性和目的性更强,避免了激素使用带来的环境污染隐患。
附图说明
图1 为dnd敲降组及对照组许氏平由的转录组数据分析情况图;
图2 为敲降组及对照组许氏平由的性腺外观图:a、b为对照组许氏平由精巢外观图,c、d为dnd基因敲降组许氏平由精巢外观图;e、f为对照组许氏平由卵巢外观图; g、h为dnd基因敲降组许氏平由卵巢外观图;
图3 为dnd敲降组及对照组许氏平由的性腺组织切片HE染色图:a、b为敲降组许氏平由精巢形态图,c、d为对照组许氏平由精巢形态图;e、f为敲降组许氏平由卵巢形态图,g、h为对照组许氏平由卵巢形态图;
图4 为dnd敲降组及对照组许氏平由孵化后270天的生长情况统计。
具体实施方式
下面通过实施例来对本发明的技术方案做进一步解释,但本发明的保护范围不受实施例任何形式上的限制。
实施例1:本实施例的实施对象是原始生殖细胞迁移、分化期的许氏平由仔鱼,在出生后120天解剖获取性腺进行形态学观察,并利用转录组测序进一步验证dnd的表达情况。
(1)许氏平由dnd基因干扰片段的选择:利用siRNA预测网站http://sidirect2.rnai.jp/,输入dnd基因ORF序列,选择目的区域,本实施例所选区域序列如SEQID NO.1所示,该区域所预测siRNA如表1所示;
表1. dnd基因干扰片段预测siRNA
(2)许氏平由dnd基因L4440-dnd干扰载体的构建:根据选取片段的序列特征,选取限制性内切酶Xba I和Hind III形成dnd基因干扰片段与L4440干扰载体的连接切口。随后使用T4连接酶将干扰片段构建到L4440线虫RNAi干扰载体上。克隆所用引物如表2所示,正向引物中6-11为Xba I内切酶切割序列TCTAGA,反向引物中6-11为Hind III内切酶切割序列AAGCTT;
表2 dnd基因干扰片段克隆引物
3)L4440-dnd干扰载体阳性HT115菌株的筛选:将构建好的L4440-dnd干扰载体转化至大肠杆菌HT115菌株中,使用四环素和氨苄青霉素两种抗性的固体平板培养基进行涂板,生长12-14h后,挑取单菌落,并进行sanger测序验证,验证结果证明测序序列与dnd基因干扰片段一致:
Sanger测序验证序列:
gcgggtgaggactggaaacctggctgaaagccaccaatacaaatctgaaacaagtaaacggccagaggaagtatggaggaccacctgaggtgtgggacgggccgtccccaggagcccgctgtgaggtcttcatcagccagatccctcgggacacctacgaggatctgctgattcccctcttcagctccgtggggcccctctgggagttccggctcatgatgaatttcagcggccagaaccgcggcttcgcctacggcaaatacggctcgccggccgtagctactgaagccatccgcctgctgcacggtcacatgctggagcccggcttctgcctcagtgtccgccgcagcacggagaagagacacctctgtatcggaaacctaagcttatcgataccgtcgacctcgagg。
(4)dnd基因敲降片段dsRNA的诱导表达:选取验证L4440-dnd阳性的HT115菌株,使用含有双抗的LB液体培养基扩繁至0.4 OD,加入IPTG诱导剂诱导dsRNA表达(IPTG终浓度为0.5mM),持续4h,并提取RNA进行验证;所述双抗的LB液体培养基成分及终浓度:胰蛋白胨10g/L、酵母提取物5g/L、NaCl 10g/L、氨苄青霉素 100mg/L和四环素 25mg/L。
(5)菌体富集:诱导结束后,4000rpm离心5min收集菌体,按照1mL重悬培养基/200mL初始菌量的比例重悬菌体;所述的重悬培养基也就是双抗的LB液体培养基。
(6)原始生殖细胞迁移、分化期许氏平由仔鱼的获取:选取处于妊娠期的健康的许氏平由雌鱼于车间内养殖,模拟自然条件下较长时间的光照,待其自然生产。
(7)人工诱导许氏平由性腺发育不良,即敲降组,同时设置对照组,敲降组和对照组各个养殖阶段投喂的饵料一样,敲降组用含有L4440-dnd干扰载体的诱导菌处理饵料,对照组用含有空载L4440的诱导菌处理饵料;其主要步骤如下所述:
①待许氏平由仔鱼产出后,取6000尾左右仔鱼放入直径1.5m,高1m,体积约为1.8m3的鱼池中,使其适应5天;
②取10mL重悬后的诱导菌混合轮虫投喂产出后5天的许氏平由仔鱼,用量为每天6000尾许氏平由仔鱼用量为10ml重悬后的诱导菌;
③投喂轮虫20天后,许氏平由饵料由轮虫更换为卤虫,处理方式同②;
④40天后,许氏平由饲料由卤虫更换为商业化颗粒饲料,处理方式如下:每天取出10mL重悬后的诱导菌,喷洒至颗粒饲料上,晒微晾干后,投喂许氏平由,用量为每天10ml/6000尾;
⑤本实施例的性腺不育处理,处理至仔鱼出生后95天;
样品获取:在仔鱼出生后120天,随机挑选对照组与敲降组许氏平由个体,剪少量尾鳍固定于95%乙醇中用于许氏平由遗传性别的鉴定,取性腺一部分置于液氮中速冻,用于RNA提取,基因表达量的分析;一部分固定于波恩氏液中用于许氏平由性腺的组织形态学观察。基因的TPM值如图1所示,敲降组dnd的TPM平均值为48.59,而对照组dnd的TPM平均值为80.22。该结果表明,敲降组dnd的表达相比对照组下调。性腺外观结果如图2所示,其中对照组精巢大小较为一致且发育良好(a-b),而敲降组精巢有明显的缺失和萎缩(c-d);对照组卵巢大小较为一致且发育良好(e-f),而敲降组卵巢有明显的缺失和萎缩(g-h)。形态学鉴定结果如图3所示,敲降组精巢出现了明显的空洞(a-b)且精原细胞明显减少,不同于雄性对照组的精巢结构(c-d);敲降组卵巢出现了较多的纤维状结构,且卵原细胞明显减少(e-f),不同于雌性对照组的卵巢结构(g-h)。
(8)由图1可以看出,投喂dnd敲降重组菌后,显著降低了许氏平由个体dnd的表达量。由图2、3可以看出,敲降组个体的性腺在外观和组织形态上出现了明显的发育不良情况。
(9)由图4敲降组个体与对照组相比可以看出,dnd敲降组许氏平由的平均体重为43.42g,对照组许氏平由的平均体重为50.49g;dnd敲降组许氏平由的平均体长为11.16cm,对照组许氏平由的平均体长为11.56cm。统计结果显示,敲降许氏平由的dnd基因,体重和体长与对照组相比并无显著差异。即投喂dnd敲降重组菌后,并不影响个体的生长性状。
Claims (6)
1.一种干扰许氏平由性腺正常发育的基因片段,其特征在于,所述基因片段的核苷酸序列如SEQ ID NO.1所示。
2.一种干扰许氏平由性腺正常发育的重组菌,其特征在于,所述重组菌包括如权利要求1中所述SEQ ID NO.1所示的基因片段、L4440线虫RNAi干扰载体和HT115菌株。
3.一种重组菌在干扰许氏平由性腺发育中的应用,其特征在于,应用方法如下:将权利要求2所述重组菌培养扩繁至OD值 0.4,诱导后,按照1mL重悬培养基/200mL初始菌量的比例重悬菌体,按照1mL/200条鱼/天的比例吸取重悬后的诱导菌,混入饵料,对处于原始生殖细胞分化期许氏平由仔鱼进行投喂,投喂周期为90天。
4.根据权利要求3所述一种重组菌在干扰许氏平由性腺发育中的应用,其特征在于,投喂时间为从许氏平由幼体生后5天开始,至出生后95天结束。
5.根据权利要求3所述一种重组菌在干扰许氏平由性腺发育中的应用,其特征在于,所述的饵料依次为轮虫、卤虫和颗粒饲料。
6.干扰许氏平由性腺正常发育重组菌的制备方法,其特征在于,将权利要求1所述的基因片段构建到L4440线虫RNAi干扰载体上,然后导入大肠杆菌HT115菌株,获得所述重组菌。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310586471.4A CN116376919A (zh) | 2023-05-24 | 2023-05-24 | 干扰许氏平由性腺正常发育的基因片段、重组菌及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310586471.4A CN116376919A (zh) | 2023-05-24 | 2023-05-24 | 干扰许氏平由性腺正常发育的基因片段、重组菌及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116376919A true CN116376919A (zh) | 2023-07-04 |
Family
ID=86964225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310586471.4A Pending CN116376919A (zh) | 2023-05-24 | 2023-05-24 | 干扰许氏平由性腺正常发育的基因片段、重组菌及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116376919A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120304323A1 (en) * | 2009-11-23 | 2012-11-29 | Aquabounty Technologies, Inc. | Maternally induced sterility in animals |
CN103088066A (zh) * | 2013-02-07 | 2013-05-08 | 中国科学院水生生物研究所 | 一种控制鱼类生殖的方法 |
US20210298276A1 (en) * | 2018-08-10 | 2021-09-30 | Center For Aquaculture Technologies, Inc. | A method of generating sterile and monosex progeny |
US20210315188A1 (en) * | 2018-10-02 | 2021-10-14 | Vestlandets Innovasjonsselskap As | Genetically modified salmon which produce sterile offspring |
CN115851732A (zh) * | 2022-12-02 | 2023-03-28 | 中国海洋大学 | 一种许氏平鲉雄性性逆转干扰片段、重组菌及其应用 |
-
2023
- 2023-05-24 CN CN202310586471.4A patent/CN116376919A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120304323A1 (en) * | 2009-11-23 | 2012-11-29 | Aquabounty Technologies, Inc. | Maternally induced sterility in animals |
CN103088066A (zh) * | 2013-02-07 | 2013-05-08 | 中国科学院水生生物研究所 | 一种控制鱼类生殖的方法 |
US20210298276A1 (en) * | 2018-08-10 | 2021-09-30 | Center For Aquaculture Technologies, Inc. | A method of generating sterile and monosex progeny |
US20210315188A1 (en) * | 2018-10-02 | 2021-10-14 | Vestlandets Innovasjonsselskap As | Genetically modified salmon which produce sterile offspring |
CN115851732A (zh) * | 2022-12-02 | 2023-03-28 | 中国海洋大学 | 一种许氏平鲉雄性性逆转干扰片段、重组菌及其应用 |
Non-Patent Citations (5)
Title |
---|
ABDUL RASHEED BALOCH等: "Dead-end (dnd) protein in fish—a review", 《FISH PHYSIOL BIOCHEM》, vol. 47, pages 777 - 784, XP037495257, DOI: 10.1007/s10695-018-0606-x * |
GENBANK: "PREDICTED: Sebastes umbrosus DND microRNA-mediated repression inhibitor 1 (dnd1), transcript variant X2, mRNA,ACCESSION XM_037779247", 《GENBANK》, pages 1 - 2 * |
刘晨斌等: "鱼类性腺发育研究进展", 《水产学杂志》, vol. 32, no. 1, pages 46 - 54 * |
叶欢等: "鱼类生殖细胞移植的研究进展及应用前景", 《水产学报》, vol. 44, no. 02, pages 777 - 784 * |
林小涵等: "miR- 430对斑马鱼原始生殖细胞迁移和 性腺发育影响的初步研究", 《中国海洋大学学报》, vol. 52, no. 3, pages 72 - 79 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rakaj et al. | Spawning and rearing of Holothuria tubulosa: A new candidate for aquaculture in the Mediterranean region | |
CN100421551C (zh) | 半滑舌鳎性逆转的诱导方法 | |
CN109819914B (zh) | 一种卵形鲳鲹和布氏鲳鲹的人工杂交育种方法 | |
Ranjeet et al. | Heterogeneous individual growth of Macrobrachium rosenbergii male morphotypes | |
CN106222204B (zh) | 一种黄鳝基因编辑的方法 | |
CN108849657A (zh) | 一种马氏珠母贝亲贝促熟培育方法 | |
CN108967278A (zh) | 一种金钱鱼的人工繁殖方法 | |
CN102960280A (zh) | 一种遗传学方法培育黄颡鱼超雄鱼及全雄鱼的方法 | |
CN101627737B (zh) | 青蟹家系的建立和良种选育方法 | |
CN103891647B (zh) | 一种香港牡蛎耐高盐新品系的制种方法 | |
CN101457233B (zh) | 构建小球藻表达载体、转化小球藻和破壁小球藻的方法 | |
Cheng et al. | Aquaculture of the tropical sea cucumber, Stichopus monotuberculatus: Induced spawning, detailed records of gonadal and embryonic development, and improvements in larval breeding by digestive enzyme supply in diet | |
CN103141411B (zh) | 一种灰海马亲海马配对方法 | |
CN101884311A (zh) | 半滑舌鳎家系构建及优良家系选育方法 | |
AU2021104593A4 (en) | Cultivation method of first-generation commercial seed hybrids of female Patinopecten caurinus and male Patinopecten yessoensis | |
CN110301381A (zh) | 一种双孔鱼的人工繁殖方法 | |
CN114208735A (zh) | 一种利用回交育种技术培育香港牡蛎三倍体快速生长新品系的方法 | |
Sato et al. | Triploidy in tambaqui Colossoma macropomum identified by chromosomes of fish larvae | |
CN108795940A (zh) | 一种运用RNAi有效防治鳞翅目害虫的方法 | |
CN115851732B (zh) | 一种许氏平鲉雄性性逆转干扰片段、重组菌及其应用 | |
CN104872036B (zh) | 克氏原螯虾在同一池塘中一年三季繁养方法 | |
Litvinenko et al. | Experimental studies to increase the natural resources of brine shrimp Artemia in hyperhaline reservoirs | |
CN116376919A (zh) | 干扰许氏平由性腺正常发育的基因片段、重组菌及其应用 | |
CN111115833A (zh) | 一种景观水体控制丝状藻生长增加水体观赏性的方法 | |
Liu et al. | The clam, Xishi tongue Coelomactra antiquata (Spengler), a promising new candidate for aquaculture in China |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20230704 |
|
RJ01 | Rejection of invention patent application after publication |